Clinical Trial

Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.

Study acronym: AML_MenALLO
Recruiting
View on ClinicalTrials.gov →
Summary
The white blood cells of patients with acute myeloid leukemia that have undergone allogeneic stem cell transplantation will be investigated. These are patient where the leukemia has returned after the transplantation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-30.
Trial Details
NCT Number NCT07627568
Lead Sponsor University of Freiburg
Conditions Acute Myeloid Leukemia
Enrollment 20 participants
Start Date 2026-05-30
Primary Completion 2027-05-30 (estimated)
Study Completion 2027-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-10